Telehealth and discount medicines provider GoodRx has been ordered to pay a $1.5 million fine by the US authorities for sharing its customers' sensitive health information
The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.